Detalhe da pesquisa
1.
Dabrafenib plus trametinib in patients with relapsed/refractory BRAF V600E mutation-positive hairy cell leukemia.
Blood
; 141(9): 996-1006, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108341
2.
Characterization of B-cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS-CoV-2 infection.
J Med Virol
; 95(10): e29179, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877800
3.
Update on hairy cell leukemia.
Clin Adv Hematol Oncol
; 16(3): 205-215, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29742076
4.
The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach.
Br J Haematol
; 166(2): 177-88, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24697238
5.
Class II human leucocyte antigen DRB1*11 in hairy cell leukaemia patients with and without haemolytic uraemic syndrome.
Br J Haematol
; 166(5): 729-38, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24931452
6.
Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.
Blood
; 119(14): 3330-2, 2012 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22210875
7.
Evidence of canonical somatic hypermutation in hairy cell leukemia.
Blood
; 117(18): 4844-51, 2011 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21368287
8.
COVID-19 in patients with classic and variant hairy cell leukemia.
Blood Adv
; 7(23): 7161-7168, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37729613
9.
Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.
Blood Rev
; 51: 100888, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34535326
10.
Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.
Nat Genet
; 54(8): 1103-1116, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835913
11.
VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.
Blood
; 114(21): 4687-95, 2009 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-19745070
12.
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.
Blood Adv
; 5(23): 4807-4816, 2021 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607348
13.
Genetic regulation of OAS1 nonsense-mediated decay underlies association with risk of severe COVID-19.
medRxiv
; 2021 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34282422
14.
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.
J Clin Oncol
; 38(14): 1527-1538, 2020 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32109194
15.
Expression of the muscle-associated gene MYF6 in hairy cell leukemia.
PLoS One
; 15(2): e0227586, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32040482
16.
Generation of antibody-based therapeutics targeting the Idiotype of B-cell Malignancies.
Antib Ther
; 2(1): 1-10, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30801054
17.
Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.
Cytometry B Clin Cytom
; 96(4): 275-282, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077558
18.
PRAME expression in hairy cell leukemia.
Leuk Res
; 32(9): 1400-6, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18295331
19.
Immunoglobulin light chain repertoire in hairy cell leukemia.
Leuk Res
; 31(9): 1231-6, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17462732
20.
Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction.
Clin Cancer Res
; 12(9): 2804-11, 2006 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16675574